Latest News for: pleural

Edit

Malignant Pleural Mesothelioma Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, NDA Approvals, Medication, ...

GetNews 14 Mar 2025
"Malignant Pleural Mesothelioma Market" ... Key Malignant Pleural Mesothelioma Companies ... Key Malignant Pleural Mesothelioma biomarkers like calretinin, WT-1, and mesothelin help differentiate Malignant Pleural Mesothelioma from other pleural diseases.
Edit

Malignant Pleural Effusion Market Expected to rise, 2034 | RS Oncology, Genelux Corporation, Candel Therapeutics, ...

GetNews 12 Mar 2025
"Malignant Pleural Effusion Market Expected to rise by 2034, DelveInsight" ... Some of the key highlights from the Malignant Pleural Effusion Market Insights Report. ... As of today, no approved drug exists for the treatment of malignant pleural effusion.
Edit

Pleural Diseases Market Expected to rise, 2032 | Chiesi Farmaceutici, Faron Pharmaceuticals, Actelion Pharmaceuticals, Meril ...

GetNews 03 Mar 2025
"Pleural Diseases Market Expected to rise, DelveInsight" ... Some of the key highlights from the Pleural Diseases Market Insights Report. ... 9 Pleural Diseases Treatment Algorithm, Pleural Diseases Current Treatment, and Medical Practices.
  • 1
×